Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19Monique G.P. van der Wijst, Chun Ye, Sabrina A Mann et al.|Science Translational Medicine|2021Cited by 237
Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccinePaul Bastard, Jean‐Laurent Casanova|The Journal of Experimental Medicine|2021Cited by 236
Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patientsRutger Koning, Esther J. Nossent, Paul Bastard et al.|Intensive Care Medicine|2021Cited by 132
Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohortRaphaël Carapito, Anne Thomas, Richard Y. Li et al.|Science Translational Medicine|2021Cited by 125
Herpes simplex encephalitis in a patient with a distinctive form of inherited IFNAR1 deficiencyPaul Bastard, Shen‐Ying Zhang|Journal of Clinical Investigation|2020Cited by 111